Skip to main content
Conavi Medical Corp. logo

Conavi Medical Corp. — Investor Relations & Filings

Ticker · CNVI TSXV Manufacturing
Open in API
Filings indexed 346 across all filing types
Latest filing 2025-03-04 Regulatory Filings
Country CA Canada
Listing TSXV CNVI

About Conavi Medical Corp.

https://www.conavi.com/

Conavi Medical Corp. is a medical device company focused on designing, manufacturing, and marketing image guidance technologies for minimally invasive cardiovascular procedures. Its flagship product is the Novasight Hybrid System, which provides simultaneous, co-registered Intravascular Ultrasound (IVUS) and Optical Coherence Tomography (OCT) imaging using a single catheter and pullback. This hybrid approach offers comprehensive visualization of coronary arteries, combining the high resolution of OCT for lumen assessment with the depth of IVUS for vessel wall analysis. The system is intended to guide complex Percutaneous Coronary Interventions (PCIs) by providing additional diagnostic information over single-modality imaging.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate press release (news release) regarding new U.S. intracoronary imaging guidelines and Conavi’s commentary. It contains forward-looking statements, contact details, and is not a financial report, earnings release, regulatory notice of share activity, or any other specific filing type. It is a general announcement distributed via TSXV/OTC newswire, fitting the fallback “Regulatory Filings” category (RNS).
2025-03-04 English
News release - English.pdf
Earnings Release Classification · 1% confidence The document is a press release summarizing Conavi Medical’s unaudited interim financial results for the quarter ended December 31, 2024, with operational highlights, revenue, expense and net loss figures, and a CEO quote. It is not the full interim report but an initial announcement of quarterly results. This fits the definition of an Earnings Release (ER). Q1 2025
2025-03-03 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is Form 52-109FV2, a certification by the CFO of interim filings (financial report and MD&A) under Canadian NI 52-109. It is not the interim report itself nor an announcement of dividend, voting, or financing. It is a standalone regulatory compliance certificate. This falls into the fallback “Regulatory Filings” category (RNS).
2025-03-03 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 “Venture Issuer Basic Certificate” by the CEO certifying the interim filings under Canadian NI 52-109. It is not the interim financial report or MD&A itself but rather the required certification that accompanies those filings. It does not announce dividend amounts, management changes, earnings, or a new report publication, nor does it contain financial data or presentation slides. It fits best as a miscellaneous regulatory filing under “Regulatory Filings” (RNS).
2025-03-03 English
Interim MD&A - English.pdf
Management Reports Classification · 1% confidence The document is titled “Management’s Discussion and Analysis” (MD&A) for the quarter ended December 31, 2024. It provides management’s detailed discussion of financial position, results of operations, business trends, forward-looking information, and reference to interim condensed financial statements. This corresponds exactly to our “Management Reports” category.
2025-03-03 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 1% confidence The document contains detailed interim condensed consolidated financial statements, including the statement of financial position, statement of loss and comprehensive loss, statement of changes in equity, and statement of cash flows for Conavi Medical Corp. for the three-month period ended December 31, 2024. It includes extensive notes to the financial statements. This meets the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. Q1 2025
2025-03-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.